Summit Therapeutics IncNASDAQ:SMMT
- LAST PRICE4.7800
- TODAY'S CHANGE (%)-0.1800 (-3.6290%)
- Bid / Lots4.7700/ 3
- Ask / Lots4.8000/ 5
- Open / Previous Close5.0100 / 4.9600
- Day Range
- 52 Week Range
- Volume2,082,413
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SMMT |
|---|---|---|
| 09:32 ET | 25988 | 5.13 |
| 09:34 ET | 4952 | 5.01 |
| 09:36 ET | 1398 | 5.04 |
| 09:38 ET | 3365 | 5.01 |
| 09:39 ET | 13365 | 4.94 |
| 09:41 ET | 2574 | 4.92 |
| 09:43 ET | 13503 | 4.9 |
| 09:45 ET | 12099 | 4.845 |
| 09:48 ET | 4202 | 4.84 |
| 09:50 ET | 8039 | 4.8395 |
| 09:52 ET | 1600 | 4.825 |
| 09:54 ET | 17289 | 4.835 |
| 09:56 ET | 11447 | 4.91 |
| 09:57 ET | 29895 | 4.865 |
| 09:59 ET | 4835 | 4.902 |
| 10:01 ET | 6144 | 4.9 |
| 10:03 ET | 1112 | 4.89 |
| 10:06 ET | 11896 | 4.869 |
| 10:08 ET | 8180 | 4.87 |
| 10:10 ET | 1200 | 4.885 |
| 10:12 ET | 6478 | 4.93 |
| 10:14 ET | 1205 | 4.915 |
| 10:15 ET | 1888 | 4.9 |
| 10:17 ET | 4158 | 4.895 |
| 10:19 ET | 6399 | 4.88 |
| 10:21 ET | 4043 | 4.88 |
| 10:24 ET | 833 | 4.89 |
| 10:26 ET | 5389 | 4.88 |
| 10:28 ET | 14651 | 4.86 |
| 10:30 ET | 7924 | 4.85 |
| 10:32 ET | 7855 | 4.85 |
| 10:33 ET | 62091 | 4.78 |
| 10:35 ET | 9610 | 4.77 |
| 10:37 ET | 7626 | 4.7508 |
| 10:39 ET | 1296 | 4.755 |
| 10:42 ET | 10989 | 4.73 |
| 10:44 ET | 8717 | 4.745 |
| 10:46 ET | 660 | 4.76 |
| 10:48 ET | 2821 | 4.77 |
| 10:50 ET | 4582 | 4.8 |
| 10:51 ET | 300 | 4.7885 |
| 10:53 ET | 6585 | 4.775 |
| 10:55 ET | 19025 | 4.79 |
| 10:57 ET | 10264 | 4.77 |
| 11:00 ET | 5573 | 4.78 |
| 11:02 ET | 4107 | 4.7868 |
| 11:04 ET | 7278 | 4.765 |
| 11:06 ET | 118902 | 4.69 |
| 11:08 ET | 39122 | 4.67 |
| 11:09 ET | 3258 | 4.69 |
| 11:11 ET | 17960 | 4.69 |
| 11:13 ET | 2597 | 4.68 |
| 11:15 ET | 6181 | 4.7 |
| 11:18 ET | 6966 | 4.72 |
| 11:22 ET | 4780 | 4.71 |
| 11:24 ET | 500 | 4.7 |
| 11:26 ET | 3236 | 4.7 |
| 11:27 ET | 813 | 4.71 |
| 11:29 ET | 2200 | 4.7199 |
| 11:31 ET | 2400 | 4.705 |
| 11:33 ET | 1200 | 4.7002 |
| 11:36 ET | 200 | 4.705 |
| 11:38 ET | 4698 | 4.725 |
| 11:40 ET | 3344 | 4.71 |
| 11:42 ET | 8414 | 4.74 |
| 11:44 ET | 1150 | 4.735 |
| 11:45 ET | 25479 | 4.772 |
| 11:47 ET | 6790 | 4.775 |
| 11:49 ET | 3750 | 4.775 |
| 11:51 ET | 118579 | 4.775 |
| 11:54 ET | 2183 | 4.745 |
| 11:56 ET | 1982 | 4.745 |
| 11:58 ET | 1001 | 4.745 |
| 12:00 ET | 4463 | 4.73 |
| 12:02 ET | 1200 | 4.725 |
| 12:03 ET | 7526 | 4.735 |
| 12:05 ET | 7092 | 4.735 |
| 12:07 ET | 3994 | 4.725 |
| 12:09 ET | 100 | 4.725 |
| 12:12 ET | 3700 | 4.73 |
| 12:14 ET | 1298 | 4.735 |
| 12:16 ET | 1000 | 4.74 |
| 12:18 ET | 4293 | 4.71 |
| 12:20 ET | 920 | 4.7088 |
| 12:21 ET | 17579 | 4.72 |
| 12:23 ET | 500 | 4.73 |
| 12:25 ET | 1500 | 4.72 |
| 12:27 ET | 1400 | 4.73 |
| 12:30 ET | 700 | 4.73 |
| 12:32 ET | 1331 | 4.73 |
| 12:34 ET | 400 | 4.73 |
| 12:36 ET | 1700 | 4.725 |
| 12:38 ET | 13864 | 4.76 |
| 12:39 ET | 3729 | 4.745 |
| 12:41 ET | 1000 | 4.7508 |
| 12:43 ET | 600 | 4.76 |
| 12:45 ET | 5624 | 4.78 |
| 12:48 ET | 1900 | 4.8175 |
| 12:50 ET | 14314 | 4.85 |
| 12:52 ET | 5851 | 4.865 |
| 12:54 ET | 42270 | 4.855 |
| 12:56 ET | 2800 | 4.835 |
| 12:57 ET | 2920 | 4.845 |
| 12:59 ET | 717 | 4.85 |
| 01:01 ET | 1200 | 4.8599 |
| 01:03 ET | 4080 | 4.88 |
| 01:06 ET | 600 | 4.87 |
| 01:08 ET | 3810 | 4.835 |
| 01:10 ET | 1516 | 4.83 |
| 01:12 ET | 9780 | 4.84 |
| 01:14 ET | 900 | 4.845 |
| 01:15 ET | 800 | 4.85 |
| 01:17 ET | 9019 | 4.86 |
| 01:19 ET | 2300 | 4.845 |
| 01:21 ET | 2184 | 4.825 |
| 01:24 ET | 1900 | 4.84 |
| 01:26 ET | 5000 | 4.8301 |
| 01:28 ET | 26837 | 4.735 |
| 01:30 ET | 7729 | 4.78 |
| 01:32 ET | 4863 | 4.78 |
| 01:33 ET | 7478 | 4.765 |
| 01:35 ET | 1663 | 4.785 |
| 01:37 ET | 1321 | 4.775 |
| 01:39 ET | 2000 | 4.78 |
| 01:42 ET | 5907 | 4.765 |
| 01:44 ET | 1427 | 4.775 |
| 01:46 ET | 6273 | 4.765 |
| 01:48 ET | 1520 | 4.77 |
| 01:50 ET | 1826 | 4.79 |
| 01:51 ET | 718 | 4.8 |
| 01:53 ET | 1600 | 4.8 |
| 01:55 ET | 3158 | 4.795 |
| 01:57 ET | 1009 | 4.79 |
| 02:00 ET | 1643 | 4.795 |
| 02:02 ET | 4069 | 4.79 |
| 02:04 ET | 350 | 4.795 |
| 02:06 ET | 17186 | 4.77 |
| 02:08 ET | 4793 | 4.765 |
| 02:09 ET | 850 | 4.765 |
| 02:11 ET | 2863 | 4.81 |
| 02:13 ET | 14694 | 4.817 |
| 02:15 ET | 2891 | 4.805 |
| 02:18 ET | 1000 | 4.8 |
| 02:20 ET | 6714 | 4.8194 |
| 02:22 ET | 2300 | 4.825 |
| 02:24 ET | 1300 | 4.83 |
| 02:26 ET | 6126 | 4.8301 |
| 02:27 ET | 2816 | 4.835 |
| 02:29 ET | 3100 | 4.84 |
| 02:31 ET | 5300 | 4.855 |
| 02:33 ET | 6555 | 4.83 |
| 02:36 ET | 1000 | 4.815 |
| 02:38 ET | 3843 | 4.845 |
| 02:40 ET | 200 | 4.85 |
| 02:42 ET | 1700 | 4.85 |
| 02:44 ET | 12286 | 4.84 |
| 02:45 ET | 2757 | 4.845 |
| 02:47 ET | 3254 | 4.835 |
| 02:49 ET | 11671 | 4.835 |
| 02:51 ET | 3130 | 4.8505 |
| 02:54 ET | 500 | 4.8575 |
| 02:56 ET | 1752 | 4.845 |
| 02:58 ET | 5914 | 4.81 |
| 03:00 ET | 27982 | 4.8 |
| 03:02 ET | 13749 | 4.825 |
| 03:03 ET | 559 | 4.83 |
| 03:05 ET | 2225 | 4.82 |
| 03:07 ET | 3108 | 4.84 |
| 03:09 ET | 600 | 4.84 |
| 03:12 ET | 9034 | 4.81 |
| 03:14 ET | 407 | 4.805 |
| 03:16 ET | 500 | 4.81 |
| 03:18 ET | 1200 | 4.805 |
| 03:20 ET | 2816 | 4.81 |
| 03:21 ET | 5652 | 4.82 |
| 03:23 ET | 11652 | 4.81 |
| 03:25 ET | 1968 | 4.815 |
| 03:27 ET | 1010 | 4.815 |
| 03:30 ET | 4946 | 4.825 |
| 03:32 ET | 10420 | 4.805 |
| 03:34 ET | 32317 | 4.795 |
| 03:36 ET | 1235 | 4.795 |
| 03:38 ET | 2696 | 4.79 |
| 03:39 ET | 10159 | 4.795 |
| 03:41 ET | 9879 | 4.825 |
| 03:43 ET | 9805 | 4.825 |
| 03:45 ET | 6792 | 4.845 |
| 03:48 ET | 11239 | 4.83 |
| 03:50 ET | 18046 | 4.815 |
| 03:52 ET | 8208 | 4.835 |
| 03:54 ET | 11191 | 4.825 |
| 03:56 ET | 18331 | 4.815 |
| 03:57 ET | 26543 | 4.82 |
| 03:59 ET | 109389 | 4.78 |
May 7, 2024
DJ Summit Therapeutics Initiated at Buy by Citigroup, from 8:27AM ET on Tuesday May 07, 2024 by Dow Jones
8:27AM ET on Tuesday May 07, 2024 by Dow Jones
May 1, 2024
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones*DJ Summit Therapeutics 1Q Loss/Shr 6c >SMMT, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones
Apr 24, 2024
Press Release: Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:46PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:46PM ET on Wednesday Apr 24, 2024 by Dow JonesSummit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Summit Therapeutics Inc | 3.5B | -3.1x | --- |
Biohaven Ltd | 3.6B | -7.3x | --- |
Xenon Pharmaceuticals Inc | 3.2B | -15.6x | --- |
Iovance Biotherapeutics Inc | 3.7B | -7.1x | --- |
SpringWorks Therapeutics Inc | 3.1B | -8.3x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Company Information
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Contact Information
- Headquarters
- 2882 Sand Hill Road, Suite 106MENLO PARK, CA, United States 94025
- Phone
- 650-460-8308
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Chief Executive Officer
- Robert Duggan
- President, Co-Chief Executive Officer, Director
- Mahkam Zanganeh
- Chief Financial Officer
- Ankur Dhingra
- Chief Operating Officer, Director
- Manmeet Soni
- Lead Non-Executive Independent Director
- Kenneth Clark
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.5B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 702.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.26 |
EPS | $-1.54 |
Book Value | $0.11 |
P/E Ratio | -3.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
